Human plasma has not gained general acceptance as a therapeutic agent because of the risk of hepatitis following its use. A number of physical and chemical treatments have been tried to minimize this risk but the incidence remains about 0.5 per cent for single donor plasma and upwards of 20 per cent for some lots of pooled plasma (1, 2) . Ultraviolet irradiation, which at one time seemed quite promising, proved incapable of inactivating the hepatitis virus at radiation doses which allowed preservation of the integrity of the plasma proteins. Another physical agent, heat, has demonstrated the ability to reduce markedly, if not completely eliminate, the hepatitis risk in human albumin (3) . In this situation an albumin solution containing a stabilizer is heated for 10 hours at 600 C. This treatment does not modify the protein to an extent which makes it unsuitable for infusion. After more than a decade of wide use, a substantiated case of hepatitis caused by injection of heated human albumin has yet to be reported.
Just as the usefulness and safety of albumin are well recognized, so also are the problems of its high cost, complexity of production, and relatively small yield as compared to plasma. Because of these factors a number of individual investigators and industrial concerns set out to develop a plasma expander which would be as useful therapeutically as albumin, but which would be less expensive and have no greater risk of transmitting hepatitis. Added impetus was given to this program by the need of the Office of Defense Mobilization and the Department of Defense for a safe plasma expander to be manufactured from their outdating stockpile of plasma.
On the basis of the work of Gellis and associates (3) and of Murray (1) on the heating of albumin, most of the investigators involved decided that a major effort should be devoted to developing a plasma derivative which could be heated without adversely affecting the constituent proteins. Murray and co-workers had shown previously (4) that the heating of whole plasma for 4 hours at 60°C produced gross changes in the proteins and did not eliminate hepatitis infectivity. It was hoped, however, that the evidence for heat inactivation of virus in albumin could be extrapolated to plasma. The main problem was to develop a procedure which would stabilize the proteins, allowing the plasma derivative to be heated for at least 10 hours at 600 C without significant alteration.
The problem was approached in two somewhat different ways. Some of the workers hoped to solve the dilemma by the use of whole plasma to which had been added a chemical stabilizer in order to minimize protein denaturation. Other workers used modifications of the recognized plasma fractionation procedures, intending thereby to eliminate those fractions of plasma which seemed most susceptible to heat denaturation. They hoped that the partially fractionated final product would turn out to be as heat stable and safe as albumin, but less expensive than that preparation.
With the cooperation of the National Research Council, this laboratory had the opportunity of doing simultaneous analyses on these various plasma preparations in an attempt to detect and perhaps evaluate some of the physical and chemical changes which were taking place as a result of the treatments. This report will present comparative data on eight such preparations. When unheated controls were available, they were similarly studied. All materials were also compared with normal unheated citrated plasma.
MATERIALS AND METHODS
As mentioned previously, the preparations were of two general types: heated whole plasma, and heated, partially fractionated plasma protein solutions. Three of the preparations, designated [1] , [2] and [3] , were in the first group and five, designated [E], were in the second. The methods of production will be described briefly and are summarized in Table I. 1953 Preparation [1] was iiia(le by heatinig for 10 hours at 600 C plasnma wlvich liad l)een irra(liated with ultraviolet light according to the requirements of the National Institutes of Health (5) and in which standard acid-citratedextrose (6) had been used as an anticoagulant. In preparing [2] , serum was filtered, heated at 550 C for 10 hours, refiltered, and then lyophilized. Preparation [3] consisted of plasma in 4 per cent citrate as an anticoagulant to which had beeni added 5 per cent invert sugar. This solution was irradiated with ultraviolet light, filtered, and then heated at 600 C for 10 hours. It is noteworthy that in two of these three preparations a sugar was used in an attempt to achieve some stabilization of the proteins. In the other, no stabilizer was used, all precipitated protein beinig removed after heating.
[A] was prepared by the method of Hink, Hidalgo, Seeberg and Johnson (7) . This consisted essentially of fractionating plasnma by method 6 of Cohn and co-workers (8) with precipitation of fractions 1, II + III, and IV-1. The supernatant IV-1 was precipitated with cold ethanol and the precipitate dried. The precipitate was dissolved in a solution of water, 0.112 M sodium chloride, 0.004 M sodium acetyltryptophanate, and 0.004 M sodium caprylate (9) , and heated for 2 lhours at 600 C, filtered into final containers and then heate(d at 600 C for 10 hours. (11) . The method of Surgenor and co-workers (12) was used for preparing [E] . This utilized a zinic precipitatioIn teclhInique to remove fibrinogen, -y-globulin, and some p-lipoproteinis. Zinc was removed from the supernataint by an ion exchange resin, following which the solution was heated at 600 C for 10 hours in the presence of sodium caprylate. This material is frequently called "stable plasma protein solution."
Our purpose in carrying out this study was to provide a preliminary evaluation of these products that would help in determining which ones, if any, would merit more detailed, intensive investigation. With this in mind, the following procedures were included in this preliminary screening: gross examination, testing for sterility and pyrogen according to the requirements of the National Institutes of Health (13), protein concelntration b)y microKjeldahl, noniproteini nitrogeni, sodium, potassium, thermal stability, electrophoresis, and ultracentrifugation.
Thermal stability was evaluated by the method described in Reference 13, usinig an Aminco light-scattering microphotometer. Incubation conditions of 500 C for 12 days, 570 C for 50 hours, and -200 C for 24 hours for separate samples were utilized. Electrophoresis was performed by the movinig boundary method in an AmincoStern apparatus, using barbital buffer at pH 8.6 and 0.1 ionlic strength. Mobilities were determined in the usual manniier, and relative proportions by the method of completion of the curves and planimetry. Ultracentrifugation xwas performed on a Spinco model E ultracentrifuge using the sedimentation velocity techlnique on the protein solutioni dialyzed against phosplhate buffered saline at pH 7.2, 0.154 ionlic strength. Sedimentation coefficients and relative proportionis were both computed. Sodium and p)otassium determiniations were made by flame photometry on a Baird flame photometer.
RESULTS AND DISCUSSION
The requirements of a plasmiia expander to be held in a stockpile would seem to be tlhreefold: 1) the material miiust be safe for iinfusion in large amounts and at frequent intervals; 2) it must be able to withstand storage and shipment under a considerable range of temperature without undergoing significant changes in the constituents; and 3) it mutst provide the therapeutic effect desired, namelV, 0lood 01volumie expansion. The investigation described herein is an attemiipt to provide a preliminary in(lication of the ability of these preparations to fulfill the first two demands. The third is best evaluated by actual clinical trial and thus merits investigation only after the safety and stability of the material are proved.
The sterility tests failed to demonstrate bacterial contamlination inl any of the preparations. In none of the preparations was the pyrogen reaction greater than that usually considered acceptable.
Simple inspection revealed interesting informiiation on several preparations. A tabulation of the gross appearance of the various materials is shown in Table I . In preparation [3] a progressively increasing reddish-brown color was noted. A much less marked darkening was also noted in preparation [1 ] . * Units are arbitrary "nephelometric uniits" (13) .
Preparations [B] and [E] had nonprotein ni-and [E]
between lack of thermal stability, or lack trogen values which were appreciably higher than of stability on shipment, and higher nonprotein nithose found in any of the other materials. There trogen values. It is of interest that although [B] seems to be some correlation in samples [B] , [C] , and [C] had the same amounts of sodium acetyl- The high sodium concentrations in preparations [1] , [3] , [B] and [E] , and the high potassium concentration in [B] give some cause for concern because these values are above both physiological levels and those found in normal citrated plasma. On this basis one would be hesitant about administering them in conditions characterized by sodium retention or renal insufficiency.
[ The low temperature instability of the whole plasma preparations is consistent with, and probably a result of lipoprotein denaturation at low temperatures as described by Oncley, Gurd and Melin (14) . The low temperature instability noted in [E] is not as readily understandable, but may also be a reflection of the presence of significant amounts of lipoprotein.
The results of the electrophoretic analyses are given in Table IV , the patterns in Figures 1 and 2. [AI Heated lii( n (Al Unheated These demonstrate marked changes in the heated whole plasmas containing sugar, i.e., [1] and [3] . These changes consist primarily of decreases in proteins moving with mobilities of albumin and /3-and y-globulins, and marked increases in proteins having mobilities comparable to those of a2-globulins. This is consistent with the findings of Miyamoto, Sakagishi and Sano (15), Ardry (16) , and Bozzetti and Prina (17) . On electrophoretic examination, preparation [2] These findings on electrophoresis together with the color changes previously noted nmay be indicative, among other things, of a type of protein degradation characterized by an initial reaction between the protein and reducing sugars. This type of "browning reaction" occurring in systems containing amine groups and reducing sugars is treated exhaustively by Hodge (18) . This reaction may be of great significance in influencing the stability of protein solutions. Suggestive evidence is indicated in the electrophoretic patterns of Figure 1 , in which the changes in preparation [2] , a material with no added reducing sugar, are significantly less marked than those in preparations [1] and [3] , both of which have added reducing sugars. The lower temperature of heating of preparation [2] may also be significant in lessening the changes detected by electrophoresis. A number of unpublished observations in our laboratory, however, tend to support the idea that the addition of reducing sugars to certain protein systems may potentiate protein denaturation. This problem is currently under investigation by our group in an attempt to determine its significance.
The results of the ultracentrifugal analyses are indicated in Table V and in Figures 3 and 4. Preparations [1] , [3] , [B] and [E] revealed measurable amounts of very rapidly sedimenting material. All of the other preparations exhibited a relatively rapid sedimenting component having an so20,w greater than 10 and less than 18. It is noteworthy that in preparation [A] no rapidly sedimenting component is present in the unheated control. It would be unusual for significant amounts of relatively high molecular weight substance to remain in a preparation after any of the fractionation procedures previously described.
One is probably justified, therefore, in assuming that the appearance of significant amounts of rapidly sedimenting component in the fractionated preparations is a result-of the formation of high molecular weight species during heating. The presence of relatively large amounts of rapidly sedimenting component in the whole plasma preparations may similarly be attributed to heating or storage, since these components are not ustually seeni in inlore thaln trace amiiouints in either serumi or plasmiia which lhas not been concentrated prior to centrifugation.
CoNCLUSIONS
The purpose of this study was to attempt to obtain a preliminary indication of the possible potential clinical usefulness of the various heated plasma )reparations. It was hloped that on the basis of a few selected physical and chemiiical tests, some asstumptionis could be made regarding the safety of the products. Certainly, the final judgment regarding safety can depend only on appropriate intensive immunological, toxicological, and clinical studies. However, an attempt was made to determine which preparations seemed most promising and would merit the intensive studies necessary to establish whether they were safe and potent enough for routine clinical use.
On the basis of these tests, we felt that a certain number of conclusions could be drawn which would allow the preparations to be graded as to their relative promise. Certain products could be put into the doubtful category because of their inability to withstand shipment and/or temperature extremes without giving indications of protein change. These would include at least preparations [B] and [E] , and most likely preparations [1] , [2] and [3] . Some products were in doubt because of findings in the electrophoretic and/or ultracentrifugal analyses which seemed to indicate major changes in the proteins. We were primarily concerned with the appearance of the rapidly sedimenting component which was present in relatively large amounts in certain of these products. Because of the experience with dextran, which seemed to indicate an adverse effect of very high molecular weight colloidal substances on the clotting system (19) , and because of the possibility of reticuloendothelial blockade by high molecular weight abnormal proteins with an adverse effect on the reaction of this system to the shock situation (20, 21) , we believed caution was necessary in any in vivo preparations testing of [1] , [2] , [3] , [B] and [E] , the same preparations put in doubt by the stability studies.
Three of the preparations, [A], [C] and [D] , all fractionated materials, seemed the most prom-ising on the basis of these preliminary physical and chemical determinations. These three preparations demonstrated relatively good stability characteristics, showed less marked changes on electrophoresis and ultracentrifugation than the others, and contained a high proportion of albumin (greater than 80 per cent) which brought them close in character to a material which has already proved clinically safe and effective, normal serum albumin (human).
The clinical significance of the changes noted in any of the preparations is unknown at this time.
SUMMARY
Eight heated plasma preparations were compared by a number of physical and chemical techniques. These tests demonstrated better stability characteristics and resistance to molecular change in those preparations which had undergone a partial fractionation procedure prior to heating. Three preparations produced by different fractionation methods were deemed to be the most promising as possible plasma expanders for human use and meriting further study both in vivo and in vitro. These were, respectively, a precipitate from supernate IV-1 of Cohn's fractionation method 6, fractions IV + V from Cohn's method 6, and a preparation from the supernate of plasma 45 per cent saturated with ammonium sulfate.
